Posts by: Carolina Henriques

Carolina Henriques

Carolina holds a BSc in Anthropology and a MSc in Urban Studies., and brings her interdisciplinary skills to her writing on a range of different topics in science, research and advocacy news.

July 21, 2017July 21, 2017

Data Lacking to Explain Why US Doctors Prefer Keppra to Treat Pediatric Epilepsy, Researchers Say

News

Doctors have several anti-seizure options to treat epilepsy, but little data exists to show which of these treatments is best for children. Nevertheless, according to a recent study on therapies ... Read more

July 19, 2017July 19, 2017

EU Regulators to Hold Public Hearing on Valproate Therapies’ Effect on Pregnant Women

News

The European Medicines Agency has scheduled an unprecedented public hearing in September on whether epilepsy therapies that contain sodium valproate pose a risk to pregnant women. It will be the first time the European Union’s ... Read more

July 14, 2017

Cleveland Clinic Researcher Wins $3.4 Million Grant to Develop Better Predictor of Epileptic Surgery Outcomes

News

The National Institutes of Health has awarded a $3.4 million grant to a Cleveland Clinic-led research collaboration whose objective is to come up with a more comprehensive model for predicting epilepsy surgery ... Read more

June 28, 2017June 28, 2017

Nearly Half of Epileptics Forget to Take Their Meds at Least Once a Month, Poll Shows

News

Almost half of epilepsy patients surveyed in a British poll say they’ve forgotten to take their medications at least once in the past month. Researchers at Epilepsy Research UK wanted to know how ... Read more

June 2, 2017

Three Epilepsy-device Inventors Share $200,000 in Shark Tank Competition

News

A portable electroencephalogram recorder, a sound-based seizure detection system, and a device that can predict seizures have won the Epilepsy Foundation’s Shark Tank Competition for epilepsy innovations. The winners will share $200,000 that ... Read more

May 24, 2017

Herantis Granted US Patent for Therapeutic Use of MANF for Epilepsy, Other Neurological Diseases

News

Herantis Pharma was granted a patent by the U.S. Patent and Trademark Office (USPTO) for the use of MANF (mesencephalic astrocyte-derived neurotrophic factor) in the treatment of neurological diseases like epilepsy, ... Read more

April 5, 2017

Europe Grants Orphan Drug Status to Epidiolex to Treat Severe Form of Children’s Epilepsy

News

The European Union has granted orphan drug status to the cannabinoid therapy Epidiolex to treat Lennox-Gestaut syndrome (LGS), a treatment-resistant, childhood-onset form of epilepsy. Epidiolex, GW Pharmaceuticals‘ lead cannabinoid (CBD) product candidate, is a proprietary ... Read more

March 29, 2017March 29, 2017

Zynerba Completes Enrollment for Two Phase 2 Trials of ZYN002 for Epilepsy and Osteoarthritis

News

Zynerba Pharmaceuticals has completed enrollment in two Phase 2 clinical trials evaluating ZYN002 cannabidiol (CBD) gel in adults with epilepsy and osteoarthritis. Cannabidiol is a non-psychoactive cannabinoid. Naturally occurring cannabinoids ... Read more

March 24, 2017March 24, 2017

11th National Walk for Epilepsy Fundraiser Is March 25 in Washington, DC

News

The Epilepsy Foundation is hosting the 11th National Walk for Epilepsy on Saturday, March 25, leading the fight to overcome the challenges of living with epilepsy and to raise funds for faster ... Read more

March 22, 2017March 22, 2017

Physician-Family Panel Recommends Actions to Better Diagnose, Treat Dravet Syndrome

News

Thirteen specialists in epilepsy and Dravet syndrome, along with five family members of children with the disease, have jointly developed a set of recommendations for better diagnosis and management of the ... Read more